2-formyl-5-(hydroxymethyl)pyrrole-1-norleucine has been researched along with Hyperglycemia, Postprandial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daimon, M; Hirata, A; Igarashi, M; Kameda, W; Kato, T; Ohnuma, H; Oizumi, T; Saitoh, T; Sugiyama, K; Yamaguchi, H | 1 |
1 other study(ies) available for 2-formyl-5-(hydroxymethyl)pyrrole-1-norleucine and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes.
Topics: Acrolein; Adult; Arginine; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Lysine; Male; Middle Aged; Norleucine; Pyrroles; Smoking | 2003 |